KUKJE PHARMA Co., Ltd.(KR:002720)
₩3,165.00-40.00 (-1.25%)
KR:002720
KUKJE PHARMA Co., Ltd. financials statements
₩3,165.00
At close:-40.00 (-1.25%)
Want to see KR:002720 full AI Analyst Report?
KUKJE PHARMA Co., Ltd. (002720) Income Statement
KUKJE PHARMA Co., Ltd. Income Statement
Last quarter (Q2 2026), KUKJE PHARMA Co., Ltd.'s total revenue was ₩48.32B, an increase of 7.32% from the same quarter last year. In Q2, KUKJE PHARMA Co., Ltd.'s net income was ₩1.67B. See KUKJE PHARMA Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 175.50B | ₩ 156.46B | ₩ 135.37B | ₩ 126.58B | ₩ 119.75B | |
| ₩ 92.97B | ₩ 82.50B | ₩ 67.22B | ₩ 63.25B | ₩ 54.47B | |
| ₩ 86.78B | ₩ 75.79B | ₩ 69.21B | ₩ 57.98B | ₩ 56.15B | |
| Depreciation and Amortization | ₩ 3.23B | ₩ 3.20B | ₩ 4.20B | ₩ 4.49B | ₩ 4.42B |
| ₩ 9.41B | ₩ 11.02B | ₩ -1.04B | ₩ 10.23B | ₩ 4.08B | |
| ₩ 6.18B | ₩ 6.70B | ₩ -1.99B | ₩ 5.27B | ₩ -401.29M | |
| ₩ 258.58M | ₩ -92.40M | ₩ -4.69B | ₩ -527.44M | ₩ 565.65M | |
| ₩ 6.44B | ₩ 6.61B | ₩ -6.68B | ₩ 4.75B | ₩ -1.11B | |
| ₩ 5.70B | ₩ 5.21B | ₩ -8.42B | ₩ 3.56B | ₩ -1.56B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 279.51 | ₩ 255.64 | ₩ -415.49 | ₩ 175.58 | ₩ -76.77 |
| Diluted EPS | ₩ 279.51 | ₩ 255.64 | ₩ -415.49 | ₩ 175.58 | ₩ -76.77 |
| Weighted Average Shares Outstanding | 20.38M | 20.36M | 20.25M | 20.26M | 20.27M |
| Weighted Average Shares Outstanding (Diluted) | 20.38M | 20.36M | 20.25M | 20.26M | 20.27M |
Currency in KRW
